Evaluation of Vancomycin Dosing in Patients With Cirrhosis: Beginning De-Liver-ations about a New Nomogram

被引:5
作者
Regal, Randolph E. [1 ]
Ren, Steven P. [2 ]
Paige, Gregory [3 ]
Alaniz, Cesar [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Xcenda AmerisourceBergen, Palm Harbor, FL USA
[3] Sav On Drugs, Livonia, MI USA
关键词
anti-infectives; infectious diseases; monitoring drug therapy; SERUM CREATININE; RENAL-FUNCTION; PHARMACOKINETICS; CLEARANCE;
D O I
10.1177/0018578718772266
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Reduced hepatic production of creatinine precursors in patients with decompensated cirrhosis leads to falsely low serum creatinine values. Therefore, when performing empiric dosing of vancomycin, an overestimation of creatinine clearance may result in significantly supratherapeutic vancomycin levels and increased risks of nephrotoxicity. Objective: The objective of the study is to evaluate vancomycin dosing requirements in patients with cirrhosis stratified by Child-Pugh Score, with subsequent comparison with doses that are recommended in the previously published and validated Kullar nomogram. Methods: A retrospective evaluation of patients with cirrhosis who received vancomycin for at least 3 full days and had at least 1 serum concentration drawn. Vancomycin daily dose and corresponding serum concentration were collected with patients stratified by Child-Pugh Score for comparison. Each patient had their vancomycin dose compared with the dose suggested by a published nomogram. Results: A total of 201 courses of vancomycin were followed. There were no significant differences between the Child-Pugh cohorts with respect to initial vancomycin dosing. There was also no significant difference in the median initial vancomycin trough concentration between the 3 cohorts (Child-Pugh A: 13.7 mu g/mL [interquartile range, IQR: 10.4-22.1]; Child-Pugh B: 20.2 mu g/mL [IQR: 15.1-25.9]; Child-Pugh C: 19.3 mu g/mL [IQR: 14.9-25.2, P = .08]. The median vancomycin dose using the Kullar nomogram would have been 3.0 g/day (IQR: 2.0-3.75, P < .001), but the median dose actually used in this patient population was significantly less at 2.0 g/day. Nonetheless, the median vancomycin trough concentration in the entire patient population was 19.8 mu g/mL (IQR: 15.4-25.9). Conclusion: In patients with cirrhosis, there was a high incidence of supratherapeutic vancomycin serum concentrations despite the fact that dosing was significantly less than that suggested by the published Kullar nomogram.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 21 条
[1]   Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer [J].
Aldaz, A ;
Ortega, A ;
Idoate, A ;
Giráldez, J ;
Brugarolas, A .
THERAPEUTIC DRUG MONITORING, 2000, 22 (03) :250-257
[2]   The metabolic burden of creatine synthesis [J].
Brosnan, John T. ;
da Silva, Robin P. ;
Brosnan, Margaret E. .
AMINO ACIDS, 2011, 40 (05) :1325-1331
[3]   The role of dietary creatine [J].
Brosnan, Margaret E. ;
Brosnan, John T. .
AMINO ACIDS, 2016, 48 (08) :1785-1791
[4]   LIMITATIONS OF SERUM CREATININE LEVEL AND CREATININE CLEARANCE AS FILTRATION MARKERS IN CIRRHOSIS [J].
CAREGARO, L ;
MENON, F ;
ANGELI, P ;
AMODIO, P ;
MERKEL, C ;
BORTOLUZZI, A ;
ALBERINO, F ;
GATTA, A .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) :201-205
[5]   Creatine supplementation with specific view to exercise/sports performance: an update [J].
Cooper, Robert ;
Naclerio, Fernando ;
Allgrove, Judith ;
Jimenez, Alfonso .
JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2012, 9
[6]   COMPARISON OF THE PHARMACOKINETIC PROPERTIES OF VANCOMYCIN, LINEZOLID, TIGECYCLIN, AND DAPTOMYCIN [J].
Estes, Kerry S. ;
Derendorf, Hartmut .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) :533-543
[7]  
Hicks Rodney W, 2011, AORN J, V93, P593, DOI 10.1016/j.aorn.2010.09.031
[8]   Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15-20 mg/L Suggested by the Vancomycin Consensus Guidelines [J].
Kullar, Ravina ;
Leonard, Steven N. ;
Davis, Susan L. ;
Delgado, George, Jr. ;
Pogue, Jason M. ;
Wahby, Krista A. ;
Falcione, Bonnie ;
Rybak, Michael J. .
PHARMACOTHERAPY, 2011, 31 (05) :441-448
[9]   Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients [J].
Lodise, Thomas P. ;
Patel, Nimish ;
Lomaestro, Ben M. ;
Rodvold, Keith A. ;
Drusano, George L. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (04) :507-514
[10]   Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: Are the equations for estimating renal function better? [J].
MacAulay, Jillian ;
Thompson, Kara ;
Kiberd, Bryce A. ;
Barnes, David C. ;
Peltekian, Kevork M. .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2006, 20 (08) :521-526